Oura buys Counsel Health for $625 million

Oura has announced that it will acquire Counsel Health for $625 million, a deal that comes after the company added Counsel Health's AI chatbot to its app earlier this year. Counsel Health describes itself as an AI-native primary care company, using artificial intelligence to deliver responses and insights through its app. The acquisition signals Oura's ambition to move beyond wearables and tracking into broader health services and clinical-style guidance. Oura is best known for its smart ring and for health metrics such as sleep, recovery, and readiness. Buying Counsel Health suggests the company wants to turn those data streams into more actionable advice and ongoing engagement. Instead of stopping at a dashboard, Oura could use AI to help users interpret symptoms, organize health questions, or navigate care. That is a significant step from consumer tracking toward services that resemble primary care. The deal also reflects growing consolidation around AI health assistants. Device makers see recurring engagement and subscription potential in health guidance, while AI-native startups bring conversational interfaces and clinical workflows. For users, the promise is more convenient, personalized support. For regulators and clinicians, the challenge is ensuring that AI-driven advice is safe, clearly bounded, and integrated with real medical care rather than replacing it. The $625 million price tag shows how much strategic value investors and acquirers place on the intersection of wearables, AI, and health services. Oura's challenge will be to combine its hardware and data with Counsel Health's care model without overpromising what an app can do. If successful, the acquisition could mark a shift from wrist- and finger-worn tracking to a more continuous, service-oriented health platform.